Auspherix raises $9.2 mln
Auspherix Limited (UK) has raised £6 million (US$9.2 million) in a Series A venture financing. Imperial Innovations plc led the round alongside Australian founding investor the Medical Research Commercialisation Fund. Stevenage, United Kingdom-based Auspherix is an an early stage anti-infectives company.
3 June 2015•5 mins read
